4th World Epigenetics Summit

04 Dec 2012 - 06 Dec 2012 - London, UK

The 4th World Epigenetics Summit provides a unique platform on which senior representatives from GSK, Constellation and Epizyme share ideas with leading academic figures such as Tony Kouzarides and Chas Bountra. In bringing together the minds behind the most exciting drugs in development, the meeting represents two days dedicated to overcoming the most pressing challenges in epigenetic drug development.

Why attend?

Get an up-to-the-minute snapshot of the very latest epigenetic target classes for disease therapy from Epizyme, GSK and Constellation Pharmaceuticals

Learn how the SGC are driving innovation by open source chemical probe design

Discover the excitement that epigenetic drugs are generating in the clinic with 4SC

Explore the potential of epigenetic modulation in non-oncological disease indications with GSK

Get excited at the potential of RNA therapeutics in a range of disease indications with RaNA Therapeutics

Find out how to optimize methods, assays and practices throughout the production pipeline so you can maximize the value of your R&D spend